Comparison study for ocular hypotensive effect of switching from Travoprost 0.004% and Timolol maleate(Timoptol®-XE ophthalmic Solution 0.5%) ,Travoprost 0.004% and long-acting 2% Carteolol to a conbined opthalmic solution Travoprost 0.004%/Timolol 0.5%
Phase 4
Recruiting
- Conditions
- Glaucoma
- Registration Number
- JPRN-UMIN000004224
- Lead Sponsor
- Department of Ophthalmology Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1Patient, who has been managed due to chronic or replace uvetis, sceritis and herpes cornea. 2.Patient, who has been managed by traumatic diseases,ocular surgery,laser operation within 3 months. 3.Patinet, who is not available to measure by Aplanation tonomater. 4.Patinet, who has irritation for PG eye solution, related PG eye solution and Benzalkonium chloride(BAC). 5.Patient, who is severe Alzheimer. 6.Patinet, who has been managed by oral CAI or steroid eye solution. 7.Patinet, who has been applied other IOP reductive drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IOP reduction
- Secondary Outcome Measures
Name Time Method Safety